TABLE 4.
List of anti-inflammatory phytochemicals used in clinical trials.
Phytochemicals | Class of compound | Disease/disorder | Assessment | References |
---|---|---|---|---|
Resveratrol | Vitis vinifera (Vitaceae) | Gulf War Illness | Improvements in cognitive functioning, functional status, mood, hippocampal neurogenesis, and functional connectivity as well as anti-inflammatory and antioxidant effects | NCT03665740 a |
Curcumin | Curcuma longa, (Zingiberaceae) | Bladder Spasm | Reducing inflammation for ureteral stent-induced symptoms | NCT02598726 a |
Malignant Neoplasm | ||||
Pain | ||||
Urinary Urgency | ||||
Epigallocatechin gallate | Camellia sinensis (Theaceae) | Obesity | To assess endotoxin and inflammatory biomarkers | NCT03413735 a |
Endotoxemia | ||||
Inflammation | ||||
Quercetin | Malus domestica, (Rosaceae) | COVID-19 | Prophylaxis and treatment of COVID-19 | NCT04377789 a |
Luteolin | Rosmarinus officinalis (Lamiaceae) | Frontotemporal Dementia | To assess the brain correlates related to the clinical improvement associated with PEA-LUT treatment | NCT04489017 a |
Indicates reference found at www.clinicaltrials.gov with corresponding identifier code (NCT).